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Purified group A streptococcal peptidoglycan-polysaccharide (PG-PS) fragments were either de-O-acylated,
or acetylated and then de-O-acylated to yield N-acetylated PG-PS. Native PG-PS was poorly degraded,
N-acetylated PG-PS was extensively degraded, and de-O-acylated PG-PS was only slightly degraded by hen egg
white lysozyme. N-acetylated PG-PS was also extensively degraded by human lysozyme and partially degraded
by rat serum or rat liver extract. After a single intraperitoneal injection of rats with a sterile, aqueous
suspension, all PG-PS preparations induced acute arthritis. The acute arthritis induced by N-acetylated PG-PS
was significantly more severe than that induced by native PG-PS; that induced by de-O-acylated PG-PS was of
intermediate severity. After the acute reaction, rats injected with native PG-PS developed chronic relapsing
erosive synovitis which remained severe for the duration of the experiment (83 days). In contrast, joint
inflammation induced by N-acetylated PG-PS resolved within 6 weeks with little evidence of recurrent disease.
Chronic arthritis induced by de-O-acylated PG-PS was of intermediate severity. In another assay of
arthropathic activity, the arthritis in all rat ankle joints, which had been injected directly with native PG-PS,
could be reactivated 3 weeks later by the intravenous injection of a small dose of PG. In contrast, only 50% of
the joints initially injected with de-O-acylated PG-PS and none of the joints injected with N-acetylated PG-PS
could be reactivated. These studies support the concepts that the resistance of PG-PS to muralytic digestion is
crucial for chronic arthropathic activity and that the nature and degree of PG acetylation are important
molecular determinants of the phlogistic activities of PG-PS polymers.
Chronic, erosive synovitis, resembling rheumatoid arthri-
tis in clinical, histologic, and radiologic detail, is induced in
rats by a single systemic injection of a sterile, aqueous
suspension of peptidoglycan-polysaccharide (PG-PS) frag-
ments purified from cell walls of group A streptococci or
other gram-positive bacteria (6, 8, 26, 38, 40, 44). A major
feature which distinguishes this from other experimental
models of arthritis is the spontaneous recurrence of episodes
of acute inflammation throughout the chronic phase of
disease. The chronic inflammation induced with group A
streptococcal PG-PS progresses over a period of several
months to joint destruction. An important bacterial determi-
nant of chronic arthropathic activity is the ability of high-
molecular-weight PG-PS fragments to resist degradation in
vivo and to localize and persist for long periods in synovial
tissue. This concept is supported by several lines of evi-
dence.
(i) Group A streptococcal PG-PS is highly resistant to
hydrolysis by leukocyte cultures, tissue extracts, or purified
lysozyme in vitro (7, 17, 19, 25, 34, 37, 40).
(ii) In several models of chronic inflammation induced by
group A streptococcal PG-PS, chronic inflammation is asso-
ciated with the deposition and persistence of PG-PS antigens
in lesions (8, 9, 12, 18, 28, 29, 33, 34, 41, 43).
(iii) Thorough removal of the PS moiety by multiple
extractions of group A streptococcal PG-PS with formamide
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yields a PG preparation which is sensitive to lysozyme (1,
24) and which induces only a transient, acute arthritis (16).
(iv) Intravenous (i.v.) injection of mutanolysin after
intraperitoneal i.p. injection of group A streptococcal PG-PS
results in the accelerated in vivo degradation of PG-PS (22)
and the lack of chronic arthritis in rats (21).
(v) Group D streptococcal PG-PS fragments, which are
sensitive to lysozyme in vitro (2, 36, 40), are not as persistent
as group A PG-PS fragments in vivo in rats (41) and induce
arthritis of much shorter duration than that induced by group
A PG-PS (40).
Increased N acetylation is known to increase the
lysozyme sensitivity of PG from several bacteria, including
group A streptococci (3, 17, 19, 20, 23, 30, 35). Decreased 0
acetylation will also result in increased lysozyme sensitivity
of PG (5, 15, 19, 30, 35). To better understand the molecular
basis of lysozyme sensitivity and its relationship to chronic
arthropathic activity, we examined the effect of acetylation
on the arthropathic activity of group A streptococcal PG-PS
fragments.
MATERIALS AND METHODS
Cell wall polymers. PG-PS was purified from the cell walls
of Streptococcus pyogenes, group A, strain D-58, or Strep-
tococcusfaecium, group D, strain ATCC 9790 as previously
described (40). This method utilizes several extractions in
sodium dodecyl sulfate to remove components present in the
cell walls which are not covalently bound to the PG-PS
polymer and to inactivate the autolytic activity of the group
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D streptococcal cell wall (35). The rhamnose content, deter-
mined by the method for determining methyl pentoses of
Dische and Shettles (10), of the group A and group D
streptococcal preparations was 27 and 18% of the dry
weight, respectively. The detailed chemical compositions of
these PG-PS polymers have been reported previously (40).
PG was prepared from purified S. pyogenes, group A,
strain D-58 PG-PS by multiple extractions with formamide
by the method of Krause and McCarty (24). The extracted
PG contained 1.9% rhamnose (14).
The sterility of cell wall polymer preparations was rou-
tinely assessed by inoculation of blood agar plates.
Acetylation and fragmentation of PG-PS. Native group A
streptococcal PG-PS was N and 0 acetylated by treatment
with acetic anhydride (Sigma Chemical Co., St. Louis, Mo.)
in sodium bicarbonate for 3 h at room temperature, washed,
and then de-O-acylated by treatment with 0.04 N NaOH for
30 min at 37°C as described by Heymann et al. (20) to yield
N-acetylated PG-PS. The pH of the reaction mixture at the
end of the acetylation step was 3.5. Another sample of group
A streptococcal PG-PS was treated with acetic acid in
sodium bicarbonate (pH 3.5) for 3 h at room temperature,
washed, and treated with NaOH as above to yield de-O-
acylated PG-PS. Finally, all three PG-PS types were frag-
mented by sonication for 35 min with the 0.5-in. (1.3-cm)
probe on a sonifier (Branson Sonic Power Co., Danbury,
Conn.) and then fractionated by differential centrifugation as
previously described (16, 40). Unless otherwise noted, all
experiments described here used fragments which sedi-
mented at 100,000 x g but not at 10,000 x g (16) (referred to
as 100P fraction). Native group A streptococcal lOOP PG-PS
fragments have an average molecular weight of 50 x 106 (16).
The acidity and basicity of the acetylation and de-O-
acylation reactions, respectively, might be expected to ex-
tract PS from the PG-PS fragments. It was important to
exclude this possibility since the removal of the PS moiety
can also modulate lysozyme sensitivity (1, 24). The
rhamnose content of the native, N-acetylated, and de-O-
acylated PG-PS 100P fragments studied here was 27.1, 27.5,
and 28.3%, respectively. The similar rhamnose content of
these preparations indicated that extraction of PS did not
occur. Although different lots of chemically modified PG-PS
have behaved similarly, all the specific experiments de-
scribed herein were done with the above lots to facilitate
biological activity comparisons.
A small sample of unfragmented native group A strepto-
coccal PG-PS was acetylated with [3H]acetic anhydride
(New England Nuclear Corp., Boston, Mass.) by the method
of Araki et al. (4). Briefly, 30 mg of native PG-PS was
suspended in 1 ml of saturated sodium bicarbonate, to which
was added 10 mg of [3H]acetic anhydride, followed by
incubation with mixing at 4°C for 24 h. Unlabeled acetic
anhydride (150 ,ul) was then added, and incubation was
continued for another 18 h at 4°C. The labeled PG-PS was
then washed and de-O-acylated as described above to yield
N-[3H]acetylated group A streptococcal PG-PS (3.1 x 103
cpm/,ug [dry weight]).
Sensitivity of PG-PS to muralytic enzymes. Preliminary
studies with unfragmented PG-PS showed that the optimum
pH for lysis of N-acetylated PG-PS by hen egg white
lysozyme was pH 5 (85% lysis in 2 h), confirming the results
of Gallis et al. (17), although considerable activity was also
seen at pH 7 and 9 (51 and 55% lysis in 2 h, respectively).
Therefore, all other studies with muralytic enzymes were
done at pH 5.
The sensitivity of the 100P fraction of native, de-O-
acylated, and N-acetylated group A streptococcal PG-PS
fragments to hen egg white lysozyme (Sigma) was assessed
in three ways as follows.
(i) Suspensions (4 ml) of PG-PS fragments (4 mg/ml) in 0.1
M sodium acetate buffer (pH 5.0) were incubated with
lysozyme (400 p,g/ml) at 37°C. The A560 of the suspension
was recorded at various times up to 24 h.
(ii) The reaction mixture described above was also sam-
pled at several intervals for determination of free reducing
groups by the method of Thompson and Shockman (42).
Samples (100 ,u) were placed at 98°C for 10 min and
immediately cooled and held at 4°C until assayed. Glucose
was used as a standard, and the slight background activity
seen in controls of lysozyme alone in acetate buffer (0.08
Rmol of glucose equivalents per 400 ,ug of lysozyme per ml)
was taken into account.
(iii) After 24 h of incubation, the PG-PS degradation
products in the reaction mixture described above were
analyzed by gel filtration on Bio-Gel A-150m (1.5 x 108-
molecular-weight exclusion limit; Bio-Rad Laboratories,
Richmond, Calif.). Samples (250 ,ul) were applied to a
column (1 by 27 cm) equilibrated with phosphate-buffered
saline (pH 7) (PBS) containing 0.02% sodium azide, with a
flow rate of 8.5 ml/h. All samples were gently sonicated for
3 min in a 9 kHz sonic oscillator (Raytheon Co., Waltham,
Mass.) to break up small aggregates of PG-PS fragments
which tend to form upon storage in the cold. Column
fractions were assayed for carbohydrate content by the
phenol-sulfuric acid method (11).
In addition, the sensitivity of unfragmented N-[3H]acety-
lated group A streptococcal PG-PS to muralytic enzymes
from a variety of sources was examined. N-[3H]acetylated
PG-PS (10 ,ul; 1.82 x 105 cpm) was suspended in 0.1 M
sodium acetate (pH 5.0) containing 0.02% sodium azide. Hen
egg white lysozyme (35 ,ug; Sigma), human milk lysozyme
(35 jig; Sigma), normal rat serum (25 or 50 pul), or rat liver
extract (25 or 50 pI) was added at time zero. The final
reaction volume in each case was 340 pI. After incubation
for 20 h at 37°C, the reaction mixtures were centrifuged at
15,000 x g for 10 min in a microcentrifuge (Fisher Scientific
Co., Pittsburgh, Pa.), and the radioactivity in the superna-
tant fluid was determined by liquid scintillation counting and
expressed as the percentage of the total radioactivity in the
reaction mixture, minus 0.5% for release of radioactivity
seen in a control reaction of N-[3H]acetylated PG-PS incu-
bated in buffer alone. The size distribution of N-
[3H]acetylated PG-PS fragments in these supernatants was
analyzed by gel filtration. Supernatants (200 pI containing at
least 104 cpm) were applied to a column (1 by 30 cm) of
Sephacryl S-200 (200,000-molecular-weight exclusion limit;
Pharmacia Fine Chemicals, Piscataway, N.J.) or Bio-Gel P-2
(1,600-molecular-weight exclusion limit; Bio-Rad) equili-
brated in PBS. The flow rate (10 ml/h) and fraction size (1 ml)
was the same for both columns. The radioactivity of each
fraction was determined and expressed as the percentage of
the total radioactivity applied to the column. The rat serum
and liver extract used above were prepared from a normal,
previously uninjected rat. Liver (10 g) from an exsanguin-
ated rat was minced in 32 ml of sterile PBS and then
homogenized in a glass tissue grinder. The crude extract was
clarified by centrifugation at 9,000 x g for 15 min and
filtration through a 0.45-,um-pore-size filter.
Experimental animals and induction of arthritis. Outbred
female Sprague-Dawley rats 6 to 8 weeks old were obtained
from Zivic-Miller Laboratories, Allison Park, Pa. Eight to
ten rats were used per group. Arthritis was induced by
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injection of sterile suspensions of the 100P fraction of PG-PS
fragments in PBS by either the intraarticular (i.a.) or i.p.
route as previously described (8, 13, 14, 40). PG-PS frag-
ments were sonicated for 3 min in the Raytheon sonicator
immediately before injection to ensure an even suspension.
In some experiments, PG was injected i.v. 3 weeks after the
i.a. injection of PG-PS fragments (14). PG was sonicated in
the Raytheon sonicator for 15 min at a concentration of 3
mg/ml of PBS immediately before dilution and injection into
rats. Dosages of PG-PS or PG used are indicated in the
Results. Injection volumes were 10 1d for i.a. and 0.5 ml for
i.p. or i.v. injections.
The severity of inflammation in each extremity was scored
grossly on a scale of 0 (no apparent inflammation) to 4
(severe inflammation) based on erythema and edema of the
periarticular tissues and enlargement of the joints, as previ-
ously described (8, 14, 40). The maximum score possible
after i.a. injection was 4 (inflammation developed only in the
ankle injected with PG-PS polymers), or 16 after an i.p.
injection (inflammation was assessed in the joints of each
extremity distal to the knees and elbows). After i.p. injection
of PG-PS fragments, an occasional rat (fewer than 10%)
showed no evidence of joint inflammation. However, the
responses of all rats were included in the statistical calcula-
tions, even though some of these negative responses were
probably due to inadvertent injection into the intestine.
Histology. Rats were killed, and skinned ankle joints were
removed, fixed in 10% Formalin, and decalcified in EDTA.
Paraffin sections were then prepared and stained with
hematoxylin and eosin. Each stained section was examined
and scored for inflammatory changes in the tissues of the
ankle and adjacent tarsal joints, as described in detail
previously (8, 40).
Radiology. Rats were anesthetized with an intramuscular
injection of Innovar (droperidol-fentanyl citrate; McNeil
Laboratories, Inc., Ft. Washington, Pa.), and ankles were
radiographed with a microradiographic unit (Foxitron model
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FIG. 1. Change in A56o of suspensions of native, de-O-acylated,
or N-acetylated group A streptococcal 100P PG-PS fragments (4
mg/ml) treated with hen egg white lysozyme (400 ,ug/ml) in vitro. To
show the increase in A560 observed in all suspensions immediately
after the addition of lysozyme, the time zero points represent the
A560 immediately before lysozyme addition, and the 3-min points
represent the A560 just after lysozyme addition. The dilution of the
reaction mixture upon the addition of lysozyme was negligible. The
actual A560s of the PG-PS suspensions at time zero were: native,
0.600; de-O-acylated, 0.519; N acetylated, 0.480. There was no
change in the A560 of control suspensions incubated for 24 h in buffer
without lysozyme (data not shown).
TABLE 1. Reducing groups liberated by digestion of native,
de-O-acylated, or N-acetylated group A streptococcal 100P PG-PS
fragments with hen egg white lysozyme in vitroa
Reducing groups (p.mol of glucose
PG-PS equivalents/mg of PG-PS)
Time zero 24 h
Native 0.06 0.16
De-O-acylated 0.07 0.31
N acetylated 0.04 0.52
a Reaction mixtures from the experiment described in the legend to Fig. 1
were sampled and assayed for free reducing group content, using glucose as a
standard. No change in free reducing group content was observed in control
suspensions incubated for 24 h in buffer without lysozyme (data not shown).
diographs were evaluated for evidence of joint damage as
described in detail previously (6, 40).
RESULTS
Sensitivity of PG-PS preparations to lysozyme. Degradation
of native, de-O-acylated, or N-acetylated group A strepto-
coccal 100P PG-PS fragments in vitro by hen egg white
lysozyme was examined by three methods: decrease in A560
of a suspension of PG-PS fragments (Fig. 1); release of free
reducing groups with time, which reflects the hydrolysis of
glycosidic bonds in the PG (Table 1); and appearance of
low-molecular-weight PG-PS degradation products (Fig. 2).
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FIG. 2. Bio-Gel A-150m gel filtration elution profiles of native,
de-O-acylated, or N-acetylated group A streptococcal 100P PG-PS
fragments after 24 h of incubation with (-) or without (0) hen egg
white lysozyme. Samples were taken from the 24-h time point of the
experiment described in the legend to Fig. 1. The VO and VT were
determined with native group A streptococcal PG-PS fragments and
glucose, respectively.
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TABLE 2. In vitro degradation of unfragmented N-[3H]acetylated
group A streptococcal PG-PS by muralytic enzymes from
various sources
r% RadioactivityEnzyme prepn Amt solubilizeda
Lysozyme
Hen egg white 35 p.g 89.0
Human milk 35 jig 77.8
Rat serum 50 ,u1 15.5
25 ,u 9.6
Rat liver extract 50 p.l 9.9
25 ,u 4.9
a Solubilization of unfragmented N-[3H] acetylated group A streptococcal
PG-PS was determined after incubation for 20 h at 37°C with various enzyme
preparations as described in Materials and Methods. The above figures take
into account 0.5% release of radioactivity from a control reaction of N-
[3H]acetylated PG-PS incubated in buffer alone.
By all three criteria, the N-acetylated PG-PS was exten-
sively degraded. Lysozyme caused only a slight decrease in
the A56 of the native PG-PS suspension (Fig. 1). However,
a small but significant release of reducing groups from native
PG-PS was noted after 24 h (Table 1). In addition, gel
filtration analysis of native PG-PS degradation products (Fig.
2) revealed the loss of a small amount of high-molecular-
weight material (the percentage of total carbohydrate eluted
in fractions 15 to 26 decreased from 94 to 81%) and the
appearance of a small amount of low-molecular-weight ma-
terial (the percentage of total carbohydrate eluted in frac-
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FIG. 3. Gel filtration of soluble labeled degradation products
liberated from unfragmented N-[3H]acetylated group A streptococ-
cal PG-PS which had been digested for 20 h with muralytic enzymes
from various sources. Supernatant fluids from the reaction mixtures
described in Table 2 were filtered on Sephacryl S-200 (200,000-
molecular-weight exclusion limit). The insert is a Bio-Gel P-2
(1,600-molecular-weight exclusion limit) filtration profile of N-
[3H]acetylated PG-PS fragments solubilized by rat serum. The V0
and VT for both columns were determined with dextran (2 x 106
molecular weight) and glucose (180 molecular weight), respectively.
PG-PS was slightly degraded by lysozyme, at a level inter-
mediate to that of native and N-acetylated PG-PS, by all
three criteria.
Immediately after the addition of lysozyme, the A560 of all
the PG-PS fragment suspensions rose (Fig. 1). This effect
was most pronounced with the de-O-acylated PG-PS frag-
ments and was difficult to assess with the N-acetylated
PG-PS fragments which were simultaneously rapidly de-
graded. This effect was also noted with suspensions of
unfragmented group A streptococcal PG-PS particles, in
which agglutination and precipitation occurred within 15 min
after lysozyme addition. The most rapid reaction with the
unfragmented particles occurred with N-acetylated PG-PS,
followed in decreasing rate by de-O-acylated and native
PG-PS (data not shown).
Unfragmented N-[3H]acetylated group A streptococcal
PG-PS particles, which sediment at 15,000 x g, were exten-
sively solubilized by hen egg white or human lysozyme in
vitro (Table 2). Rat liver homogenate and rat serum also
possessed a significant amount of PG-PS-degrading activity
(Table 2). 3H in supernatants from suspensions hydrolyzed
with lysozyme was associated with a broad range of PG-PS
fragment sizes as judged by gel filtration (Fig. 3). Similarly,
3H in supernatants from reaction mixtures containing rat
liver extract or rat serum was retained by a 200,000-
molecular-weight exclusion limit gel and was excluded by a
1,600-molecular-weight exclusion limit gel (Fig. 3), demon-
strating that the 3H was associated with low-molecular-
weight PG-PS degradation products but not with free ace-
tate.
Arthropathic activity of PG-PS preparations injected sys-
temically. Figure 4 shows the clinical course of arthritis
induced by the i.p. injection of native, de-O-acylated, or
N-acetylated group A streptococcal 100P PG-PS fragments.
All three PG-PS types induced an acute course of arthritis
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FIG. 4. Course of arthritis induced by the i.p. injection of native
(untreated), de-O-acylated, or N-acetylated group A streptococcal
100P PG-PS fragments. The dose of PG-PS fragments was 145 p.g
(dry weight) per g of body weight. Ten rats were injected in each test
group. For clarity, standard errors are not indicated for every data
point. Statistically significant mean joint score differences: N-
acetylated PG-PS > de-O-acylated PG-PS, days 3 and 5; N-
acetylated PG-PS > native PG-PS, days 2 to 6; de-O-acylated PG-PS
> N-acetylated PG-PS, days 34 to 69; native PG-PS > de-O-
acylated or N-acetylated PG-PS, days 31 to 83 (t test for indepen-
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TABLE 3. Comparison of recurrent and chronic features of joint disease induced by group A streptococcal PG-PS fragments which
differ in acetylationa
Severity of arthritis at termination of expt (day 83)
PG-PS Relapses perratb Joint score Radiologic Histologic score
score
Native 4.0 ± 0.9c 8.3 ± 2.0 5.5 ± 1.0 10.3 ± 2.3
De-O-acylated 1.3 ± 0.6 1.3 ± 0.3 0.4 ± 0.2 5.8 ± 0.5
(P < 0.05d) (P < 0.005) (P < 0.001) (P = 0.05)
N acetylated 0.9 ± 0.5 0.7 ± 0.3 0.4 ± 0.2 5.3 ± 0.4
(P = 0.005) (P < 0.005) (P < 0.001) (P < 0.05)
a On day 83, ankles from rats from the experiment shown in Fig. 4 were analyzed for radiologic and histologic evidence of injury, as described in Materials and
Methods.
bThe course of arthritis in each ankle and wrist joint of each rat from the experiment shown in Fig. 4 was examined for spontaneous relapses of grossly apparent
inflammation. A successive decrease and increase of at least one joint score unit was considered a relapse. The number of relapses observed in each of the four
joints was summed and expressed as the number of relapses per rat.
c Mean ± one standard error of the mean.
d P for the significance of the difference between mean for native PG-PS group versus de-O-acylated or N-acetylated PG-PS group (t test for independent
means).
by native PG-PS recurred approximately 3 weeks after
injection and was still highly active at the termination of the
experiment. This chronic phase of arthritis was character-
ized by repeated episodes of remission and exacerbation of
inflammation in individual limbs (Table 3).
Acute arthritis induced by N-acetylated PG-PS was more
severe than that induced by native PG-PS (Fig. 4) but
resolved with little or no evidence of recurrent inflammation
(Table 3). De-O-acylated PG-PS induced acute arthritis of
intermediate severity (Fig. 4) which also resolved with little
evidence for recurrent inflammation (Table 3). However,
grossly apparent joint inflammation induced by de-O-
acylated PG-PS resolved more slowly and was statistically
more severe from days 34 to 69 than that induced by
N-acetylated PG-PS (Fig. 4).
At the termination of the experiment (day 83) the ankle
joints of all rats were examined for histologic and radiologic
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FIG. 5. Course of arthritis induced in the right ankle joint by the
ia. injection, on day zero, of 10 jig (dry weight) of native (un-
treated), de-O-acylated, or N-acetylated group A streptococcal 1OOP
PG-PS fragments or native (untreated) group D streptococcal 1lOP
PG-PS fragments. Left ankle joints injected with saline did not
develop arthritis at any time. Eight rats were used per test group.
For clarity, standard errors are not indicated for every data point.
The i.v. injection on day 26 of 300 jig of PG induced a recurrence of
arthritis in eight of 'eight joints initially injected with native group A
streptococcal PG-PS, four of eight joints injected with de-0-acylated
group A PG-PS, and none of the joints injected with N-acetylated
group A or native group D streptococcal PG-PS. Statistically
significant mean joint score differences: native, or de-O-acylated
group A PG-PS > N-acetylated group A or native group D PG-PS,
days 11 to 34; native group A PG-PS > de-O-acylated group A
PG-PS, days 28 to 34 (t test for independent means, P - 0.05).
evidence of injury. The radiologic and histologic scores for
ankles from rats injected with N-acetylated or de-O-acylated
PG-PS did not differ significantly from one another but were
significantly less than scores for ankles from rats injected
with native PG-PS (Table 3). Radiographs from rats injected
with N-acetylated or de-O-acylated PG-PS revealed a small
amount of bone demineralization, but none of the erosion,
cartilage space narrowing, soft tissue swelling, or other
damage seen in joints from rats injected with native PG-PS.
Histologic examination of ankles from rats injected with
N-acetylated or de-O-acylated PG-PS revealed a small de-
gree of chronic, erosive synovitis with fibrosis, scarring, and
limited pannus formation. However, ankles from rats receiv-
ing native PG-PS were more severely affected in all these
respects, in addition to having some acute, exudative, pro-
liferative inflammation, suggesting an active ongoing inflam-
matory reaction. Only two of the rats receiving de-O-
acylated PG-PS, and none of the rats receiving N-acetylated
PG-PS, showed histologic evidence of acute inflammation at
83 days.
Arthropathic activity of PG-PS preparations injected lo-
cally. Figure 5 shows the courses of arthritis observed in
right ankle joints injected i.a. with either native, de-O-
acylated, or N-acetylated group A streptococcal 100P PG-PS
fragments or native group D streptococcal 100P PG-PS
fragments. All PG-PS types induced an acute synovitis of
similar severity which peaked within 24 h after injection. The
course of arthritis induced by native group A PG-PS was
similar to that induced by de-O-acylated PG-PS up to 26 days
after injection. Arthritis induced by N-acetylated group A
PG-PS quickly resolved, was indistinguishable from that
induced by the lysozyme-sensitive native group D PG-PS,
and was significantly less severe than that induced by native
or de-O-acylated group A PG-PS from day 11 to the termi-
nation of the experiment. Past studies have shown that
recurrent joint inflammation is not a feature of arthritis
induced by a single i.a. injection of any of a variety of PG-PS
types (13, 14, 40).
The i.v. injection of a normally subarthropathic dose of
PG (300 rag) on day 26 induced a recurrence of arthritis in
joints which had previously received native or de-O-acylated
group A PG-PS, but not in those which had received
N-acetylated group A PG-PS or native group D PG-PS. The
recurrence of arthritis was of greater incidence and severity
in joints previously injected with native group A PG-PS than
in those injected with de-O-acylated group A PG-PS. This
finding suggests that, despite the similarity in grossly appar-
INFECT. IMMUN.
ARTHROPATHIC ACETYLATED GROUP A STREPTOCOCCAL PG-PS 21
ent disease from day 0 to day 26, there is a qualitative
difference in the nature of arthritis induced by native and
de-O-acylated group A PG-PS.
DISCUSSION
Comparison of the degradation of arthropathic group A
streptococcal PG-PS fragments by lysozyme in vitro re-
vealed that N-acetylated PG-PS was degraded extensively,
in agreement with the study of Gallis et al. (17); that native
PG-PS was degraded at a barely detectable level; and that
de-O-acylated PG-PS was degraded at a level intermediate to
that of native and N-acetylated PG-PS. Past studies of the
lysozyme sensitivity of group A streptococcal cell walls used
extremely large, unsonicated fragments that, even after
de-O-acylation, were not sensitive to lysozyme (17, 19). It is
possible that the degradation of native and de-O-acylated
PG-PS fragments seen in the present study was due to
exposure of lysozyme-sensitive bonds by sonic treatment of
large PG-PS pieces, or due to a more complete de-O-
acylation of PG-PS fragments, or both. The initial increase in
optical density of a suspension of streptococcal cell walls
incubated with a high concentration of lysozyme has been
observed previously and is attributed to a lysozyme-
mediated aggregation of cell walls (7). The degree to which
PG-PS fragments bind lysozyme in vivo is unknown, but is
potentially important in the in vivo transport and processing
of PG-PS polymers.
The chronicity of arthritis induced by a single injection of
group A streptococcal PG-PS fragments is correlated with
the resistance of the PG-PS fragments to lysozyme digestion.
Thus, only native PG-PS induced long-term, relapsing, de-
structive arthritis, while N-acetylated PG-PS induced little
or no recurrent disease, and de-O-acylated PG-PS induced
arthritis of intermediate chronicity. Arthritis induced by
N-acetylated PG-PS was of shorter duration than that in-
duced by lysozyme-sensitive native group D streptococcal
PG-PS as determined in a previous study (40). Sensitivity of
N-acetylated PG-PS to hen egg white lysozyme was corre-
lated with degradation by human lysozyme, rat serum, and
rat liver extract in vitro. Other recent investigations have
noted that PG degradation by human lysozyme in vitro (32,
39) or in rats in vivo (41) is correlated with PG degradation
by hen egg white lysozyme in vitro.
The concept that resistance to lysozyme (and, conse-
quently, the in vivo persistence) of a PG-PS polymer is an
important determinant of chronic arthropathic activity in this
experimental model is supported by the recent studies of
Lehman et al. (26, 27), Spitznagel et al. (38, 39), and
Stimpson et al. (40, 41). These studies are all based on
comparisons of PG-PS polymers from different bacterial
species which differ in sensitivity to lysozyme. Although
lysozyme sensitivity generally correlates with induction of
less chronic arthritis, the differences in disease duration
could also be due to other reasons, such as differences in the
composition and structure of the PG or PS moieties which
are unrelated to lysozyme sensitivity. The present study is
unique in that a single PG-PS type was chemically modified
to become sensitive to lysozyme. The modifications (acyla-
tion changes) did not change the chemical composition of the
PG or PS in the complex. Therefore, differences in arthritis
severity more likely reflect differences in lysozyme sensitiv-
ity and in vivo persistence. For this reason, N-acetylated
PG-PS will provide a useful negative control for future
studies of chronic arthritis.
As the lysozyme sensitivity of PG-PS increased, the
severity of acute arthritis induced by a single systemic
injection of PG-PS also increased. Previous studies have
shown a relationship between PG-PS fragment size and
arthritis chronicity. The trend is for small fragments (5 x 106
molecular weight) to induce the most severe acute arthritis,
while large fragments (>50 x 106 molecular weight) induce
the most severe chronic, recurrent disease (16). It is there-
fore likely that N-acetylated PG-PS fragments were de-
graded in vivo to a smaller size able to induce more severe
acute arthritis than that induced by slowly degraded large
native PG-PS fragments. The increased severity of acute
arthritis may be attributed in part to increased activation of
complement by the alternate pathway by certain intermedi-
ate-size PG-PS degradation products (22, 39; M. J. Janusz,
R. A. Eisenberg, and J. H. Schwab, Inflammation, in press).
The assay of induced recurrent arthritis, using a local
injection of PG-PS into the ankle joint followed several
weeks later by a systemic injection of PG, was designed to
study factors involved in epsiodes of recurrent arthritis. The
i.v. injection of a small, normally subarthropathic dose ofPG
was intended to mimic the hypothetical exposure of the
previously injured joint to material from a distant PG-PS
depot (14). In the present report, we found that as the
lysozyme sensitivity of PG-PS increased, the duration of the
course of arthritis induced by local injection decreased, and
the incidence of recurrent inflammation after i.v. PG injec-
tion decreased.
It should be noted here that although well-recognized
methods were used to N acetylate and de-O-acylate the
streptococcal PG-PS structures in this and past studies (17,
19), many details of the precise nature and extent of acyla-
tion remain obscure. Much more work is needed to fully
define the relationship between PG-PS acylation and biolog-
ical activity.
The observation that PG acylation affects the biological
properties of cell wall structures has been made in other
systems. Rosenthal and co-workers (15, 31, 32) have shown
that gonococcal PG deficient in 0 acetylation, due either to
mutation or to treatment with alkali, is digested by
lysozyme. This PG induces arthritis of decreased incidence
and severity in rats compared with that induced by
lysozyme-resistant 0-acetylated PG (15). The gonococcal
preparations are arthropathic only when injected intraderm-
ally in oil (adjuvant arthritis model), although only relatively
low systemic doses in aqueous suspension have been tested
to date (15).
Araki et al. (3, 4) have presented detailed studies on the
role of a peptidoglycan deacetylase which determines
lysozyme resistance in strains which produce this enzyme.
No evidence has been found in this study or others (17) for
the presence of mammalian enzymes which can modulate
PG acetylation, although such enzymes have not been sys-
tematically sought. The PG deacetylase from Bacillus cereus
was found in culture supernatants (4). If this enzyme is
present extracellularly among indigenous bacteria, it is con-
ceivable that PG polymers which are ordinarily sensitive to
lysozyme could be converted to resistant forms, thereby
potentially increasing host exposure to toxic, poorly biode-
gradable PG. Differences in the presence of this and other
enzymes affecting PG-PS degradation could conceivably
contribute to genetic differences in host susceptibility to
PG-PS-induced arthritis. In any event, the present study
suggests that the degree and nature of PG acetylation are
important determinants of the chronic inflammatory activity
of PG-PS polymers.
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